Compliance Rate

Compliance Rate 100.0%
Compliant submissions 1
Incompliant submissions 0
Total trials 1

My Organizations' Clinical Trials

Showing 3025 of 3173 entries
View as:

Rheumatoid Arthritis Satisfaction Outcome Research

Phase: N/A Priority: Normal
NCT ID: NCT03703817 Org: User:
Start: 07/02/18 End: 03/12/20 Due: 03/12/21

A Study To Determine The Safety, Tolerability, Skin Irritation Potential, And PK Following Topical Application Of PF-07038124 In Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT04135560 Org: User:
Start: 10/29/19 End: 04/10/20 Due: 04/10/21

A Study Of The Efficacy And Safety Of CP-601,927 Augmentation Of Antidepressant Therapy In Major Depression

Phase: N/A Priority: Normal
NCT ID: NCT01098240 Org: User:
Start: 06/14/10 End: 09/12/11 Due: 09/12/12

Formation of Antibodies and Subsequent Prediction of Clinical Response in Patients With Rheumatoid Arthritis Treated With Four TNF Blocking Agents

Phase: N/A Priority: Normal
NCT ID: NCT01691014 Org: User:
Start: 04/30/13 End: 01/31/15 Due: 01/31/16

Evaluation of the Efficacy of Novel Ibuprofen Acetaminophen Combination Formulations in the Treatment of Post-surgical Dental Pain

Phase: N/A Priority: Normal
NCT ID: NCT01559259 Org: User:
Start: 04/10/12 End: 09/13/12 Due: 09/13/13

Enbrel-Juvenile Idiopathic Arthritis (JIA) Use Results Survey [All-Case Surveillance]

Phase: N/A Priority: Normal
NCT ID: NCT01145352 Org: User:
Start: 07/31/09 End: 10/31/13 Due: 10/31/14

Work Productivity in Active Ankylosing Spondylitis (AS) Patients Treated With Enbrel.

Phase: N/A Priority: Normal
NCT ID: NCT01421303 Org: User:
Start: 10/31/09 End: 12/31/13 Due: 12/31/14

Non-Interventional Study With Aricept® Evess

Phase: N/A Priority: Normal
NCT ID: NCT00889603 Org: User:
Start: 05/31/09 End: 03/31/10 Due: 03/31/11

A Trial Assessing The Long Term Safety And Tolerability Of [S,S]-Reboxetine In Patients With Post-Shingles Pain.

Phase: N/A Priority: Normal
NCT ID: NCT00353808 Org: User:
Start: 07/31/06 End: 10/31/07 Due: 10/31/08

A Study to Learn How Different Tablets of the Study Medicine Vepdegestrant Are Taken up Into the Blood in Healthy Adults

Phase: N/A Priority: Normal
NCT ID: NCT06645938 Org: User:
Start: 10/16/24 End: 03/14/25 Due: 03/14/26

A Study to Learn How the Study Medicine Called PF-07275315 Works in Healthy People

Phase: N/A Priority: Normal
NCT ID: NCT05411588 Org: User:
Start: 06/09/22 End: 05/13/24 Due: 05/13/25

Safety And Tolerability Of Escalating Intravenous Doses Of PF-05231023 In Adult Subjects With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT01285518 Org: User:
Start: 02/28/11 End: 07/31/11 Due: 07/31/12

The Association Between Dopamine Agonists and Cardiac Valvulopathy, Fibrosis and Other Cardiopulmonary Events

Phase: N/A Priority: Normal
NCT ID: NCT01052948 Org: User:
Start: 01/31/07 End: 12/31/09 Due: 12/31/10

Acute Treatment Trial in Adult Subjects With Migraines

Phase: N/A Priority: Normal
NCT ID: NCT03872453 Org: User:
Start: 03/25/19 End: 11/11/19 Due: 11/11/20

Parecoxib in Renal Colic

Phase: N/A Priority: Normal
NCT ID: NCT00139646 Org: User:
Start: 04/30/02 End: 04/30/04 Due: 04/30/05

Study To Determine The Effect Of Food And Strong CYP3A4 Enzyme Inhibitor On PF-04449913 Drug Levels

Phase: N/A Priority: Normal
NCT ID: NCT01749085 Org: User:
Start: 12/31/12 End: 02/28/13 Due: 02/28/14

A Study To Compare Pharmacokinetics Of Dacomitinib (PF-00299804) Between Healthy Subjects And Subjects With Mild And Moderate Hepatic Impairment

Phase: N/A Priority: Normal
NCT ID: NCT01571388 Org: User:
Start: 04/30/12 End: 08/31/12 Due: 08/31/13

Non-Interventional Post Marketing Surveillance Study To Observe The Safety And Efficacy Of Vfend® Tablet In Korea

Phase: N/A Priority: Normal
NCT ID: NCT01073631 Org: User:
Start: 03/31/06 End: 10/31/09 Due: 10/31/10

Study Evaluating Serum Collected From Healthy Adults For Development of Pneumococcal Opsonophagocytic Assay

Phase: N/A Priority: Normal
NCT ID: NCT00508950 Org: User:
Start: 08/31/07 End: 06/30/16 Due: 06/30/17

Study To Evaluate The Efficacy And Safety Profile Of PF-06651600 And PF-06700841 In Subjects With Alopecia Areata

Phase: N/A Priority: Normal
NCT ID: NCT02974868 Org: User:
Start: 12/15/16 End: 05/15/19 Due: 05/15/20

A Study to Determine the Degree of Additional Reduction in CV Risk in Lowering LDL Below Minimum Target Levels

Phase: N/A Priority: Normal
NCT ID: NCT00327691 Org: User:
Start: 04/30/98 End: 08/31/04 Due: 08/31/05

A Study of PF-06651600 Effect on Rosuvastatin Pharmacokinetics in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT04092595 Org: User:
Start: 09/26/19 End: 01/15/20 Due: 01/15/21

A Study to Assess an Auto-injector Being Used to Treat a Migraine Attack

Phase: N/A Priority: Normal
NCT ID: NCT00510419 Org: User:
Start: 07/31/07 End: 12/31/07 Due: 12/31/08

Study To Assess Differential Sensitivity Of 2 Spatial Working Memory Tests In Schizophrenics Treated With Risperidone

Phase: N/A Priority: Normal
NCT ID: NCT00174200 Org: User:
Start: 12/31/04 End: 05/31/06 Due: 05/31/07

A Trial to Assess the Lot Consistency, Safety, Tolerability and Immunogenicity of Bivalent rLP2086 Vaccine When Given to Healthy Subjects Aged ≥10 to <19 Years

Phase: N/A Priority: Normal
NCT ID: NCT01830855 Org: User:
Start: 04/30/13 End: 04/30/15 Due: 04/30/16